CRABP2 and Marinesco-Sjogren syndrome: Thus, altered CRABP2 expression due to MSS-associated NFIX mutations could potentially disrupt RA signaling and lead to the skeletal abnormalities and increased fracture risk, as well as CNS anomalies that are observed in MSS patients.22